IP Library Granted Patent US 8,877,180
Granted Patent B2
US 8,877,180 · App. 13/467,736 · Granted Nov 4, 2014

Human placental collagen compositions, and methods of making and using the same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,877,180
App. No.
13/467,736
Granted
Nov 4, 2014
Kind
B2
Abstract

The present invention provides compositions comprising human placental telopeptide collagen, methods of preparing the compositions, methods of their use and kits comprising the compositions. The compositions, kits and methods are useful, for example, for augmenting or replacing tissue of a mammal.

Claims (9)

1. A composition comprising placental extracellular matrix (ECM), wherein said placental ECM comprises (i) placental collagen, wherein said collagen comprises between 74% and 92% Type I collagen by weight, 4% to 6% Type III collagen and between 2% to 15% type IV collagen by weight, (ii) glycosaminoglycans, (iii) between 3% and 5% elastin by weight, (iv) less than 0.01% laminin by weight, and (v) less than 0.01% fibronectin by weight.

2. The composition of claim 1 , wherein said placental collagen is human placental collagen.

3. The composition of claim 1 , wherein when CD34-placental stem cells are cultured on a sheet of said composition, said placental stem cells secrete higher levels of IL-6, IL-8, and MCP-1 than an equivalent number of CD34-placental stem cells cultured on a collagen-coated tissue culture surface.

4. The composition of claim 1 , wherein said collagen is cross-linked.

5. The composition of claim 1 , wherein said collagen is cross-linked with glutaraldehyde.

6. The composition of claim 1 , shaped as a sheet.

7. The composition of claim 1 , shaped as a tube.

8. The composition of claim 1 , shaped as a mesh.

9. The composition of claim 1 , wherein said composition is shaped to fit to a site of a wound or injury.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 30, 2025
From: CELULARITY INC.
To: CELENIV PTE. LTD.
Reel/Frame 073705/0109 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2018
From: CLARITY ACQUISITION II LLC
To: CELULARITY, INC.
Reel/Frame 045209/0509 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 9, 2017
From: CLARITY ACQUISITION II LLC
To: CELULARITY, INC.
Reel/Frame 044780/0261 →
MERGER Recorded Nov 8, 2017
From: ANTHROGENESIS CORPORATION
To: CLARITY ACQUISITION II LLC
Reel/Frame 044413/0680 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2013
From: BHATIA, MOHIT; LUGO, CHRIS; YE, QIAN; EDINGER, JAMES W.
To: ANTHROGENESIS CORPORATION
Reel/Frame 031310/0815 →